Recent Finacing
Recent Raise
Highlight Therapeutics is a Valencia-based biopharmaceutical company developing next-generation immuno-oncology treatments, led by its Phase 2b RNA-based candidate BO-112 for skin cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Highlight Therapeutics.
